Free Trial

PyroGenesis Canada (PYRGF) Competitors

$0.36 +0.00 (+0.06%)
(As of 12/20/2024 05:32 PM ET)

PYRGF vs. ACIU, AMLX, LFCR, ITOS, BNTC, FHTX, LRMR, ELDN, AVIR, and URGN

Should you be buying PyroGenesis Canada stock or one of its competitors? The main competitors of PyroGenesis Canada include AC Immune (ACIU), Amylyx Pharmaceuticals (AMLX), Lifecore Biomedical (LFCR), iTeos Therapeutics (ITOS), Benitec Biopharma (BNTC), Foghorn Therapeutics (FHTX), Larimar Therapeutics (LRMR), Eledon Pharmaceuticals (ELDN), Atea Pharmaceuticals (AVIR), and UroGen Pharma (URGN). These companies are all part of the "pharmaceutical products" industry.

PyroGenesis Canada vs.

PyroGenesis Canada (NASDAQ:PYRGF) and AC Immune (NASDAQ:ACIU) are both small-cap industrial products companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, earnings, profitability, valuation, risk, institutional ownership, community ranking and dividends.

AC Immune received 258 more outperform votes than PyroGenesis Canada when rated by MarketBeat users.

CompanyUnderperformOutperform
PyroGenesis CanadaN/AN/A
AC ImmuneOutperform Votes
258
62.47%
Underperform Votes
155
37.53%

0.0% of PyroGenesis Canada shares are owned by institutional investors. Comparatively, 51.4% of AC Immune shares are owned by institutional investors. 47.7% of PyroGenesis Canada shares are owned by insiders. Comparatively, 4.6% of AC Immune shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

PyroGenesis Canada has a beta of 0.76, meaning that its stock price is 24% less volatile than the S&P 500. Comparatively, AC Immune has a beta of 1.26, meaning that its stock price is 26% more volatile than the S&P 500.

AC Immune has a net margin of 0.00% compared to PyroGenesis Canada's net margin of -115.14%. AC Immune's return on equity of -28.26% beat PyroGenesis Canada's return on equity.

Company Net Margins Return on Equity Return on Assets
PyroGenesis Canada-115.14% -1,365.53% -60.81%
AC Immune N/A -28.26%-18.98%

In the previous week, AC Immune had 1 more articles in the media than PyroGenesis Canada. MarketBeat recorded 1 mentions for AC Immune and 0 mentions for PyroGenesis Canada. AC Immune's average media sentiment score of 1.08 beat PyroGenesis Canada's score of 0.00 indicating that AC Immune is being referred to more favorably in the news media.

Company Overall Sentiment
PyroGenesis Canada Neutral
AC Immune Positive

AC Immune has a consensus target price of $12.00, indicating a potential upside of 347.76%. Given AC Immune's stronger consensus rating and higher possible upside, analysts clearly believe AC Immune is more favorable than PyroGenesis Canada.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PyroGenesis Canada
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
AC Immune
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

PyroGenesis Canada has higher earnings, but lower revenue than AC Immune. PyroGenesis Canada is trading at a lower price-to-earnings ratio than AC Immune, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PyroGenesis Canada$9.14M7.25-$21.12M-$0.06-6.00
AC Immune$40.97M6.47-$60.41M-$0.46-5.83

Summary

AC Immune beats PyroGenesis Canada on 13 of the 17 factors compared between the two stocks.

Get PyroGenesis Canada News Delivered to You Automatically

Sign up to receive the latest news and ratings for PYRGF and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PYRGF vs. The Competition

MetricPyroGenesis CanadaPharmaceutical IndustryIndustrial SectorNASDAQ Exchange
Market Cap$66.22M$6.57B$9.24B$9.08B
Dividend YieldN/A3.00%2.10%4.23%
P/E Ratio-6.0010.5921.0817.18
Price / Sales7.25195.804.86116.99
Price / CashN/A57.1619.2537.86
Price / Book-36.005.094.224.78
Net Income-$21.12M$151.83M$398.18M$225.60M
7 Day Performance-12.30%-2.13%-4.86%-1.23%
1 Month Performance-24.46%-3.10%-2.10%3.36%
1 Year Performance13.10%11.54%14.80%16.60%

PyroGenesis Canada Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PYRGF
PyroGenesis Canada
N/A$0.36
+0.1%
N/A+15.9%$66.22M$9.14M-6.0090
ACIU
AC Immune
2.4741 of 5 stars
$2.97
+0.7%
$12.00
+304.0%
-33.8%$293.85M$16.48M-6.41140Positive News
AMLX
Amylyx Pharmaceuticals
4.2561 of 5 stars
$4.20
+1.9%
$7.33
+74.6%
-70.7%$287.90M$196.49M-1.08200Short Interest ↓
News Coverage
Positive News
LFCR
Lifecore Biomedical
2.9045 of 5 stars
$7.75
+1.8%
$10.00
+29.0%
+18.7%$285.41M$128.44M97.50690
ITOS
iTeos Therapeutics
3.5018 of 5 stars
$7.74
+0.8%
$25.25
+226.2%
-28.4%$282.77M$35M-2.4490Analyst Forecast
BNTC
Benitec Biopharma
3.6885 of 5 stars
$12.13
+3.1%
$24.43
+101.4%
+277.8%$281.66M$80,000.000.0020Analyst Revision
FHTX
Foghorn Therapeutics
2.8809 of 5 stars
$4.97
-6.2%
$16.00
+221.9%
-14.0%$276.30M$25.52M-2.63120Analyst Forecast
Analyst Revision
News Coverage
Gap Down
High Trading Volume
LRMR
Larimar Therapeutics
1.5624 of 5 stars
$4.31
-30.1%
$20.43
+374.0%
+4.4%$275.02MN/A-3.5630Analyst Revision
News Coverage
Positive News
Gap Down
High Trading Volume
ELDN
Eledon Pharmaceuticals
2.9252 of 5 stars
$4.54
+3.7%
$16.00
+252.4%
+196.6%$271.22MN/A-2.3310Positive News
AVIR
Atea Pharmaceuticals
3.0689 of 5 stars
$3.19
+8.9%
$6.88
+115.7%
+5.6%$269.44M$351.37M-1.5370High Trading Volume
URGN
UroGen Pharma
3.8754 of 5 stars
$11.43
+0.7%
$43.70
+282.3%
-28.4%$268.03M$82.71M-3.60200

Related Companies and Tools


This page (NASDAQ:PYRGF) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners